Herbst RS, Khuri FR, Lu C, et al. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma. Cancer. (2002)95(2):340–353.

The novel and effective nonplatinum, non

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma : Potential for decreased toxicity and combination with biologic therapy

✍ Roy S. Herbst; Fadlo R. Khuri; Charles Lu; Diane D. Liu; Frank V. Fossella; Bonn 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 545 KB

## Abstract ## BACKGROUND Gemcitabine and vinorelbine are two of the most active third‐generation agents for the treatment of advanced nonsmall cell lung carcinoma (NSCLC). The authors conducted a formal Phase II trial to evaluate the efficacy of this combination in both untreated and previously t

Herbst RS, Khuri FR, Lu C, et al. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma. Cancer. (2002)95(2):340–353.

✦ Synopsis

Abstract